- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00936286
Respiratory Muscle Training in Obstructive Sleep Apnea Syndrome (OSAS) Patients
The Impact of Respiratory Muscle Training on the Therapy of Obstructive Sleep Apnea Syndrome (OSAS) Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The obstructive sleep apnea syndrome (OSAS) is of great significance for affected individuals as well as for public health service. Patients suffer from reduced quality of life and show an increased accident risk in road traffic and on the job. Furthermore, OSAS represents an independent risk factor for cardiovascular diseases, in particular arterial hypertension.
In sleep apnea patients, the relatively early stimulation of the upper respiratory tract muscles compared to the thoracic respiratory muscles is abrogated in many cases. Alternatively, nerve damage with impaired sensory function in the pharynx area and impaired motor function of the upper air tract musculature, in particular the musculus genioglossus can be observed. The disturbed sensory function impairs the reflex activation of the genioglossus. Moreover, the pattern of neurogenic muscle damage with a loss of the pattern of different types of fibers changed to the point of adjoining atrophic and hypertrophic sections and a more monotonous appearance of fiber types could be detected. During waking hours the activity of the musculus genioglossus is enhanced compared with control persons, which is interpreted as a compensatory mechanism. During sleep time, however, this compensation seems to disappear.
In several studies either direct or indirect stimulation of the musculus genioglossus and its supplying nerves were deployed. Yet, the results were inconsistent. The direct muscle stimulation using intramuscular electrodes, although efficient, was no longer pursued due to technical reasons. Although the results of an external stimulation showed improvements regarding apneas and snoring, the findings were usually weakly pronounced. In a study ascertaining muscle training with transcutaneous electrical stimulation a significant improvement regarding snoring was achieved when compared to placebo. In general, no influence on sleep apnea syndrome could be accomplished, although there were individual cases showing a clinically relevant amelioration.
A preceding study compared habitual snorers with control persons. It was shown that respiratory muscle training by means of normocapnic hyperpnea was accompanied by enlargement of the musculus genioglossus and reduced snoring. Moreover, an increased physical performance was observed.
Thus, the question arises if training of the respiratory musculature by means of normocapnic hyperpnea leads to clinical and polysomnographical improvements in patients with mild to intermediate sleep apnea syndrome.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Nordrhein-Westfalen
-
Solingen, Nordrhein-Westfalen, Germany, 42699
- Wissenschaftliches Institut Bethanien e.V.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Mild to intermediate sleep apnea syndrome with AHI of 10 - 30/h and clinical symptoms
- Refusal of a primary nCPAP therapy
- Epworth Sleepiness Scale (ESS) score ≥ 9
- Signed informed consent form
Exclusion Criteria:
- Therapy with pharmaceuticals which can influence the musculature
- Psychiatric disease which negatively influences compliance
- Acute and chronic diseases of the lung and/or the respiratory passages
- BMI ≥ 35 kg/m²
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Respiratory Muscle Training
|
Respiratory muscle training with SpiroTiger device, 1 week training initiation and 4 weeks training period with 5 training days per week, training duration 30 min each.
Respiratory bag volume set at 50% VC, respiratory frequency starting from 50% MVV.
Weekly control trainings.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Apnea-hypopnea index, Snoring
Time Frame: 5 weeks
|
5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Polysomnography (PSG) with sleep stages, total arousal count and respiratory arousal count
Time Frame: 5 weeks
|
5 weeks
|
Clinical symptoms according to self-assessment questionnaire (Epworth Sleepiness Scale)
Time Frame: 5 weeks
|
5 weeks
|
Lung function test parameters (VC, FEV1, MVV, etc.)
Time Frame: 5 weeks
|
5 weeks
|
Nocturnal partial pressure of oxygen and/or carbon dioxide in the blood (during PSG)
Time Frame: 5 weeks
|
5 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Winfried J. Randerath, Prof. Dr., Wissenschaftliches Institut Bethanien e.V
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- WI_SpiroTiger_87/2008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstructive Sleep Apnea Syndrome
-
University of ChicagoGlaxoSmithKlineCompletedChildhood Obstructive Sleep Apnea Syndrome (OSAS)United States
-
University Hospital, GrenobleTerminatedChronic Obstructive Pulmonary Disease (COPD) | Obstructive Sleep Apnea Syndrome (OSAS)France
-
Royal College of Surgeons, IrelandUniversity College Dublin; Connolly Hospital BlanchardstownCompletedObstructive Sleep Apnoea SyndromeIreland
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingModerate Obstructive Sleep Apnea SyndromeFrance
-
Karolinska University HospitalCompletedObstructive Sleep Apnea Syndrome in ChildrenSweden
-
University of Alabama at BirminghamTerminatedObstructive Sleep Apnea Hypopnea Syndrome (OSAHS)United States
-
Sakarya UniversityUnknown
-
Haute Ecole de Santé VaudUnknownObstructive Sleep Apnea SyndromeSwitzerland
-
Karolinska University HospitalKarolinska InstitutetCompletedObstructive Sleep Apnea SyndromeSweden
-
Tyco Healthcare GroupUnknown
Clinical Trials on SpiroTiger
-
Fondazione Salvatore MaugeriCompletedChronic Obstructive Pulmonary Disease | Congestive Heart FailureItaly
-
Università degli Studi di FerraraUnknown